title: Synergistic action of DPIV and APN in the regulation of T cell function.
abstract: Inhibitors of the enzymatic activity of alanyl-aminopeptidases severely affect growth and typical functions of human peripheral T cells both in vitro and in vivo. The most prominent changes observed include the activation of cellular signal transduction pathways such as MAP kinases Erk1/2 or the Wnt-pathway, a decrease of production and release of "pro-inflammatory" cytokines (IL-2, IL-12) and, most importantly, an induction of expression and release of the immunosuppressive cytokine, TGF-beta1. Similar effects on T cell proliferation and function have been observed in response to inhibition of DPIV, which is strongly suggestive of a functional synergism of APN and DPIV. In support of this hypothesis evidence is provided showing that the simultaneous application of inhibitors of DPIV and APN further enhances the anti-inflammatory and immunosuppressive effects provoked by the inhibition of APN or DPIV alone. Therefore, the simultaneous inhibition of these enzymes represents a promising strategy for the pharmacological therapy of T cell mediated diseases such as autoimmune disease, inflammation, allergy, and allograft rejection.
authors.affiliation: Institute of Experimental Internal Medicine, Otto-von-Guericke University Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany.
authors.forename: Uwe
authors.initials: U
authors.lastname: Lendeckel
authors.forename: Marco
authors.initials: M
authors.lastname: Arndt
authors.forename: Alicja
authors.initials: A
authors.lastname: Bukowska
authors.forename: Janine
authors.initials: J
authors.lastname: Tadje
authors.forename: Carmen
authors.initials: C
authors.lastname: Wolke
authors.forename: Thilo
authors.initials: T
authors.lastname: Kähne
authors.forename: Klaus
authors.initials: K
authors.lastname: Neubert
authors.forename: Jürgen
authors.initials: J
authors.lastname: Faust
authors.forename: Annelore
authors.initials: A
authors.lastname: Ittenson
authors.forename: Siegfried
authors.initials: S
authors.lastname: Ansorge
authors.forename: Dirk
authors.initials: D
authors.lastname: Reinhold
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D018826:CD13 Antigens / Q000378:metabolism*; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004357:Drug Synergism; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics*; D008213:Lymphocyte Activation; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000235:genetics*; D053773:Transforming Growth Factor beta1
chemical_list: D015703:Antigens, CD; D016207:Cytokines; D007376:Interleukin-2; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D018826:CD13 Antigens; D018819:Dipeptidyl Peptidase 4